GLP-1 medications are certainly getting a lot of attention these days. But how safe are these medications? And do they have additional benefits beyond weight loss? On this show, Karolyn talks with researcher Kristin Altwegg, PhD, recipient of the AICR/WCRF Marilyn Gentry Fellowship. Dr. Altwegg's research is looking at GLP-1 weight loss drugs and their influence on obesity-related cancer risk, specifically breast, endometrial, and colon. Dr. Altwegg will discuss her research and the pros and cons of these medications.